Clinical Trial

Effectiveness of 10% Lidocaine on Relieving Pain Caused by Intravenous Intubation

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 1, 2025 (before its estimated December 31, 2025 completion). Its status may not reflect the trial's current state.
Summary
The goal of this clinical trial is to learn if 10% Lidocaine spray can reduce local pain caused by intravenous (IV) intubation among women. The main questions it aims to answer are: * Does 10% Lidocaine spray lower the VAS score in participants need intravenous intubation? * What size effect of 10% Lidocaine spray when patients administered? Researchers will compare 10% Lidocaine spray to a placebo (a look-alike substance that contains no drug) to see if 10% Lidocaine spray works to reduce local pain caused by intravenous (IV) intubation Participants will: * Receive 3 spray of 10% Lidocaine at intravenous catheter insertion site before the nurse perform the IV insert procedure * Assess the pain cause by IV insertion using VAS
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-09-30.
Trial Details
NCT Number NCT07212192
Lead Sponsor Phenikaa University
Conditions Pregnancy
Enrollment 150 participants
Start Date 2025-11-24
Primary Completion 2025-12-31 (estimated)
Study Completion 2026-01-25 (estimated)
Updated on ClinicalTrials.gov 2025-12-01